The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Quality of end‐of‐life care in patients with hematologic malignancies: A retrospective cohort study
Open accessAbstract
BACKGROUND: To the authors' knowledge, only limited data are available regarding the quality of end‐of‐life care for patients with hematologic malignancies. In this retrospective cohort study, the quality of end‐of‐life care was compared between patients with hematologic malignancies and those with solid tumors. METHODS: All adult patients who died of advanced cancer between September 1, 2009 and February 28, 2010 while under the care of the study institution were included. The authors collected baseline demographics and end‐of‐life care indicators, including emergency room visits, hospitalization, intensive care unit admissions, and systemic cancer therapy use within the last 30 days of life. RESULTS: Of a total of 816 decedents, 113 (14%) had hematologic malignancies. In the last 30 days of life, patients with hematologic malignancies were more likely to have emergency room visits (54% vs 43%; P = .03), hospital admissions (81% vs 47%; P < .001), ≥ 2 hospital admissions (23% vs 10%; P < .001), > 14 days of hospitalization (38% vs 8%; P < .001), intensive care unit admissions (39% vs 8%; P < .001) and death (33% vs 4%; P < .001), chemotherapy use (43% vs 14%; P < .001), and targeted therapy use (34% vs 11%; P < .001) compared with patients with solid tumors. Patients with hematologic malignancies were also less likely to have palliative care unit admissions (8% vs 17%; P = .02). The composite score for aggressiveness of care (with 0 indicating the best and 6 indicating the worst) was significantly higher among patients with hematologic malignancies compared with those with solid tumors (median, 2 vs 0; P < .001). On multivariate analysis, hematologic malignancy was found to be a significant factor associated with aggressive end‐of‐life care (odds ratio, 6.6; 95% confidence interval, 4.1‐10.7 [P < .001]). CONCLUSIONS: The results of the current study indicate that patients with hematologic malignancies received more aggressive care at the end of life. Cancer 2014;120:1572–1578. © 2014 American Cancer Society.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The National Comprehensive Cancer Network: Present and future directions
McGivney, W. T. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19980515)82:10+<2057::aid-cncr14>3.0.co;2-a · Cited by 16,766
Wright, A. A. (2008) · JAMA · doi:10.1001/jama.300.14.1665 · Cited by 2,788
Pochon, S. (2005) · American Journal of Cancer · doi:10.2165/00024669-200504040-00008 · Cited by 1,424
Trends in the Aggressiveness of Cancer Care Near the End of Life
Earle, C. C., Neville, B. A., Landrum, M. B., Ayanian, J. Z., Block, S. D., & Weeks, J. C. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.08.136 · Cited by 987
Identifying Potential Indicators of the Quality of End-of-Life Cancer Care From Administrative Data
Earle, C. C., Park, E. R., Lai, B., Weeks, J. C., Ayanian, J. Z., & Block, S. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.03.059 · Cited by 894
Wright, A. A., Keating, N. L., Balboni, T. A., Matulonis, U. A., Block, S. D., & Prigerson, H. G. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.26.3863 · Cited by 797
Temel, J. S., Greer, J. A., Admane, S., Gallagher, E. R., Jackson, V. A., Lynch, T. J., Lennes, I. T., Dahlin, C. M., & Pirl, W. F. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.32.4459 · Cited by 696
Ho, T. H., Barbera, L., Saskin, R., Lu, H., Neville, B. A., & Earle, C. C. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.31.9897 · Cited by 416
Why do patients with cancer visit the emergency department near the end of life?
Barbera, L., Taylor, C., & Dudgeon, D. (2010) · Canadian Medical Association Journal · doi:10.1503/cmaj.091187 · Cited by 395
Access to Palliative Care Among Patients Treated at a Comprehensive Cancer Center
Hui, D., Kim, S.-H., Kwon, J. H., Tanco, K. C., Zhang, T., Kang, J. H., Rhondali, W., Chisholm, G., & Bruera, E. (2012) · The Oncologist · doi:10.1634/theoncologist.2012-0192 · Cited by 218
Self-citation
Cited by
Integration of oncology and palliative care: a Lancet Oncology Commission
Kaasa, S., Loge, J. H., Aapro, M., Albreht, T., Anderson, R., Bruera, E., Brunelli, C., Caraceni, A., Cervantes, A., Currow, D. C., et al. (2018) · The Lancet Oncology · doi:10.1016/s1470-2045(18)30415-7 · Cited by 830
Self-citationHui, D., Kim, S. H., Roquemore, J., Dev, R., Chisholm, G., & Bruera, E. (2014) · Cancer · doi:10.1002/cncr.28628 · Cited by 454
Self-citationPoshtan, M. M., Aflakseir, A., Witthöft, M., Cherry, M. G., Rahimi Taghanaki, C., & Ramzi, M. (2025) · European Journal of Oncology Nursing · doi:10.1016/j.ejon.2025.102793 · Cited by 7
Metadata
- Authors
- Hui, D., Didwaniya, N., Vidal, M., Shin, S. H., Chisholm, G., Roquemore, J., & Bruera, E.
- Venue
- Cancer
- Publisher
- Wiley
- Published
- 2014-02-18
- Volume
- 120
- Issue
- 10
- Pages
- 1572-1578
- ISSN
- 0008-543X (ISSN-L)
- 1097-0142
- OpenAlex
- W1587003863
- Cited by
- 315
- References
- 26
- FWCI
- 20.83
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Quality of end‐of‐life care in patients with hematologic malignancies: A retrospective cohort study. https://app.cochat.ai/papers/10.1002/cncr.28614
- The paper
- Hui, D., Didwaniya, N., Vidal, M., Shin, S. H., Chisholm, G., Roquemore, J., & Bruera, E. (2014). Quality of end‐of‐life care in patients with hematologic malignancies: A retrospective cohort study. Cancer. https://doi.org/10.1002/cncr.28614
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.